Rare aardvark trace fossils discovered in South Africa
A recent study published in Quaternary Research describes the discovery and identification of possible aardvark tracks and ...
美银给予Aardvark Therapeutics股票22美元目标价
周一，美银证券开始对Aardvark Therapeutics Inc（NASDAQ:AARD）进行研究覆盖，给予该生物制药股票"买入"评级，目标价为22.00美元。相比当前10.13美元的股价，这一目标价显示出显著的上涨潜力，尽管 InvestingPro ...
RBC Capital给予Aardvark Therapeutics"优于大市"评级
周一，RBC Capital开始对Aardvark Therapeutics Inc（NASDAQ:AARD）进行研究覆盖，给予该股"优于大市"评级，目标价为$21.00。该股目前交易价格为$10.13，根据分析师的共识目标价$22.00，具有显著的上涨潜力。 InvestingPro ...
Aardvark Therapeutics (AARD): Among Stocks With At Least $10 Million In Insider Spending ...
We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...
Aardvark Therapeutics, Inc. Common Stock (AARD): Among Top Insider Purchases Last Month
We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...
Aardvark Therapeutics initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams initiated coverage of Aardvark Therapeutics (AARD) with an Outperform rating and $21 price target Aardvark ...
Aardvark Therapeutics initiated with a Buy at BofA
BofA initiated coverage of Aardvark Therapeutics (AARD) with a Buy rating and $22 price target The company’s lead drug ARD-101 is in Phase 3 ...
Aardvark Therapeutics (NASDAQ:AARD) Coverage Initiated at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Free Report) in a report issued on Monday morning, Marketbeat reports. The brokerage issued an overweight rating ...
Wall Street Journal27 天
Aardvark Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...